Healthcare

The GLG Healthcare Practice provides access to a global network of more than 55,000 experts from across the entire healthcare industry including physicians, researchers, scientists, and healthcare industry executives.

The Healthcare Practice provides insight into issues affecting the pharmaceutical, biotechnology, medical device, and healthcare services sectors.

Leading Experts on Healthcare

Leading Experts include Council Members from GLG Member Programs. The Gerson Lehrman Group® (GLG) LeaderSM Program is our premium Member ProgramSM. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Kevin Kearns, President, Managing Partner, 2K Healthcare SolutionsKevin Kearns

President, Managing Partner
2K Healthcare Solutions

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Kevin Kearns, MD, is a board certified internist with a diverse background in academic medicine, clinical practice, health system medical management and managed care. Dr. Kearns has been Managing Partner for 2K Healthcare Solutions since February 2009....

Stan Schofield,  Senior Vice President, MAINEHEALTHStan Schofield

Senior Vice President
MAINEHEALTH

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Stan Schofield is the President of NorDx, a regional laboratory corporation within the Maine Health System. He also serves as Senior Vice President and Senior Member of the Health System Executive Management Team. Mr. Schofield is the Founder and Managing...

John Cochran

Medical Director
Pathology Lab of Georgia

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

John Cochran, MD, is the Founder and Chief Executive Officer of Chestatee Pathology Associates in Atlanta, GA, since 2001. Dr. Cochran is Medical Director of several metro-Atlanta CLIA-licensed, accredited laboratories and founded the first independent...

Vasilios Voudouris, Chief Executive Officer, Vereniki SolutionsVasilios Voudouris

Chief Executive Officer
Vereniki Solutions

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Vasilios Voudouris is Chief Executive Officer of Vereniki Solutions, a consultancy supporting the biotech/pharma industry. He also was an Executive Director at a leading US based CMO (Ampac Fine Chemicals) until Feb 2010 and was a Department Head at Nektar...

Walter Carlini

General Neurologist
MEDFORD NEUROLOGY

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Walter Carlini, MD, PhD, is a board certified general neurologist at the Medford Neurology Clinic in Oregon. He has been in practice since 1993. His clinical interests include stroke, epilepsy, migraine, dementia, movement disorders, and multiple sclerosis....

View All Leading Experts in Healthcare

GLG Study Groups in Healthcare(?)

Study Group Name No. Members
Oncologists (US) 2194
Obstetricians/Gynecologists 2171
Pharmacists (US) 2085
Neurologists 1958
Ophthalmologists 1744

View All Study Groups in Healthcare

Engage a member of GLG Healthcare councils

Get Intelligently Connected
with the world's leading experts

GLG's 850+ Clients Include:

More than 70% of the world's leading
mutual funds
15 of the leading 20
global banks
9 of the leading 10
global private equity firms
5 of the leading 10
AmLaw firms
Fortune 500® Companies
in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software

GLG Clients have access to 65,000+ Healthcare Members Globally:

Healthcare Providers
33,000+
Healthcare Industry Experts
17,000+
Cardiologists
2,500+
Hospital Administrators
1,700+
Pharmacists
1,200+

Become a Council Member

GLG Research StudySM

245 U.S.-based neurologists share their opinion of Tysabri for the treatment of multiple sclerosis.

GLG Research Study: 245 Neurologists on Tysabri for MS

GLG Vital SignsSM

How will Revlimid's use change with this new data? How will Carfilzomib fit into a crowded market?

GLG Vital Signs: American Society of Hematology (ASH) Annual Meeting Recap: Revlimid and Carfilzomib Spotlight


Reactions from ten top medical oncologists, powered by the GLG Healthcare CouncilsSM, regarding data presented by Amgen and Bayer at the 34th European Society of Medical Oncology (ESMO) Congress in Berlin the week of September 21, 2009.

GLG Vital Signs: Post-ESMO Impact: Nexavar/Denosumab

Most Popular Healthcare Insights